BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 35875806)

  • 1. Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.
    Chopra H; Bibi S; Singh I; Kamal MA; Islam F; Alhumaydhi FA; Emran TB; Cavalu S
    Front Aging Neurosci; 2022; 14():879114. PubMed ID: 35875806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology.
    Hajipour MJ; Santoso MR; Rezaee F; Aghaverdi H; Mahmoudi M; Perry G
    Trends Biotechnol; 2017 Oct; 35(10):937-953. PubMed ID: 28666544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photobiomodulation in Alzheimer's Disease-A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
    Ailioaie LM; Ailioaie C; Litscher G
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Major Hypotheses of Alzheimer's Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment.
    Cáceres C; Heusser B; Garnham A; Moczko E
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine: A Promising Way to Manage Alzheimer's Disease.
    Khan NH; Mir M; Ngowi EE; Zafar U; Khakwani MMAK; Khattak S; Zhai YK; Jiang ES; Zheng M; Duan SF; Wei JS; Wu DD; Ji XY
    Front Bioeng Biotechnol; 2021; 9():630055. PubMed ID: 33996777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives.
    La Barbera L; Mauri E; D'Amelio M; Gori M
    Front Neurosci; 2022; 16():939855. PubMed ID: 35992936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology Therapy for Alzheimer's Disease Memory Impairment Attenuation.
    Ribarič S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases.
    Zhang L; Sun H; Chen Y; Wei M; Lee J; Li F; Ling D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1696. PubMed ID: 33463089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of nanotechnology in treatment of Alzheimer's disease.
    Cao Y; Zhang R
    Front Bioeng Biotechnol; 2022; 10():1042986. PubMed ID: 36466349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents.
    Nazem A; Mansoori GA
    J Alzheimers Dis; 2008 Mar; 13(2):199-223. PubMed ID: 18376062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges.
    Wen MM; El-Salamouni NS; El-Refaie WM; Hazzah HA; Ali MM; Tosi G; Farid RM; Blanco-Prieto MJ; Billa N; Hanafy AS
    J Control Release; 2017 Jan; 245():95-107. PubMed ID: 27889394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology.
    Kumar R; Aadil KR; Mondal K; Mishra YK; Oupicky D; Ramakrishna S; Kaushik A
    Crit Rev Biotechnol; 2022 Dec; 42(8):1180-1212. PubMed ID: 34823433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current emerging novel therapies for Alzheimer's disease and the future prospects of magneto-mechanical force therapy.
    Shen Y; Wang M; Li S; Yang J
    J Mater Chem B; 2023 Oct; 11(39):9404-9418. PubMed ID: 37721092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective.
    Puranik N; Yadav D; Song M
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings.
    Delbreil P; Rabanel JM; Banquy X; Brambilla D
    Adv Drug Deliv Rev; 2022 Aug; 187():114397. PubMed ID: 35738546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.
    Taliyan R; Kakoty V; Sarathlal KC; Kharavtekar SS; Karennanavar CR; Choudhary YK; Singhvi G; Riadi Y; Dubey SK; Kesharwani P
    J Control Release; 2022 Mar; 343():528-550. PubMed ID: 35114208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
    Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
    Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine in the Management of Alzheimer's Disease: State-of-the-Art.
    Mir Najib Ullah SN; Afzal O; Altamimi ASA; Ather H; Sultana S; Almalki WH; Bharti P; Sahoo A; Dwivedi K; Khan G; Sultana S; Alzahrani A; Rahman M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.
    Wilson B; Geetha KM
    J Control Release; 2020 Sep; 325():25-37. PubMed ID: 32473177
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.